KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Non-cash Items (2016 - 2018)

Historic Non-cash Items for Neogenomics (NEO) over the last 4 years, with Q4 2017 value amounting to $2.1 million.

  • Neogenomics' Non-cash Items rose 8652.73% to $2.1 million in Q4 2017 from the same period last year, while for Dec 2017 it was $2.1 million, marking a year-over-year increase of 8652.73%. This contributed to the annual value of $2.1 million for FY2017, which is 8652.73% up from last year.
  • As of Q4 2017, Neogenomics' Non-cash Items stood at $2.1 million, which was up 8652.73% from $2.1 million recorded in Q3 2017.
  • Neogenomics' Non-cash Items' 5-year high stood at $3.7 million during Q2 2015, with a 5-year trough of $900000.0 in Q1 2015.
  • Over the past 4 years, Neogenomics' median Non-cash Items value was $2.3 million (recorded in 2014), while the average stood at $2.3 million.
  • In the last 5 years, Neogenomics' Non-cash Items tumbled by 5676.73% in 2016 and then surged by 8652.73% in 2017.
  • Over the past 4 years, Neogenomics' Non-cash Items (Quarter) stood at $2.4 million in 2014, then grew by 9.62% to $2.6 million in 2015, then crashed by 56.77% to $1.1 million in 2016, then skyrocketed by 86.53% to $2.1 million in 2017.
  • Its Non-cash Items was $2.1 million in Q4 2017, compared to $2.1 million in Q3 2017 and $1.1 million in Q4 2016.